analysis of the use of fingolimod in patients with multiple sclerosis in a university central...

1

Upload: jose-pedro-liberal

Post on 24-Jul-2015

35 views

Category:

Documents

1 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Analysis of the use of Fingolimod in patients with multiple sclerosis in a University Central Hospital

Epilepsy Surgery in Patients with Tuberous Sclerosis · 30 Epileptologie 2013; 30 Epilepsy Surgery in Patients with Tuberous Sclerosis | H. Holthausen, T. Pieper, H. Eitel, M. Kudernatsch

Total Laryngectomy in Patients with Advanced Bulbar ... · Total Laryngectomy in Patients with Advanced Bulbar Symptoms of Amyotrophic Lateral Sclerosis ... Patients with advanced

Kappos fingolimod moa-clin_results_vfinal_buenosaires1a

Multiple Sclerosis: More Than Your A’s - IPhA tablet.pdf · pathophysiology for Multiple Sclerosis 2. List therapeutic options for patients with Multiple Sclerosis 3. Given a patient

Sphingosine 1-Phosphate Receptor Modulators for the ... · Fingolimod Fingolimod is a lipophilic agent that is phosphorylated by sphingosine kinase 1/2 to become fingolimod phosphate,

IgGs from patients with amyotrophic lateral sclerosis and ...Dec 10, 2019 · IgGs from patients with amyotrophic lateral sclerosis and diabetes target CaVα2δ1 subunits impairing

Fingolimod for the treatment of Relapsing-Remitting ... · damage in multiple sclerosis MRI = magnetic resonance imaging; MS = multiple sclerosis. Adapted from 7. Barten LJ, et al

Open access Original research Natalizumab versus fingolimod ......ButkuevenfiH etal Open 202010e0361 doi101136bmjopen20200361 1 Open access Natalizumab versus fingolimod for patients

Impaired Language Pathways in Tuberous Sclerosis … Impaired Language... · Impaired Language Pathways in Tuberous Sclerosis Complex Patients with Autism Spectrum Disorders ... white

Functional cerebral changes in multiple sclerosis … et...Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test Alexandra Ernst1,2, Vincent

Haematological Malignancies in Systemic Sclerosis Patients ...downloads.hindawi.com/journals/crirh/2017/6230138.pdf · CaseReport Haematological Malignancies in Systemic Sclerosis

Gilenya, INN-fingolimod

Long term Prognosis of Multiple Sclerosis in Untreated ... · Long-term Prognosis of Multiple Sclerosis in Untreated Patients and Patients Treated with First Generation Immunomodulators

Effectiveness of fingolimod in real-world relapsing ... · Background Fingolimod is the first oral agent approved for treatment of relapsing-remitting multiple sclerosis (RRMS). We

Sclerosis Patients Retention of Antigenicity for Multiple Causes the

T Cells of Multiple Sclerosis Patients Target a Common ... Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice1 Shawn Winer,

Different cognitive profiles of Brazilian patients with ... · patients with relapsing-remitting multiple sclerosis and primary progressive multiple sclerosis. METHOD Study/patients

Fingolimod for the treatment of multiple sclerosis: a review of the … · 2019-07-12 · Multiple sclerosis (MS) is an autoimmune disease of the brain and spinal cord for which there

Gudesblatt et al, Mult Scler Foster City 2014, 2:1 ournal ... · ournal of Multiple Sclerosis ... oral fingolimod 0.5 mg in patients with relapsing ... treatment of relapsing MS

IgGs from patients with amyotrophic lateral sclerosis and diabetes … · IgGs from patients with amyotrophic lateral sclerosis and diabetes target CaVα2δ1 subunits impairing islet

Ungefiltert, unredigiert und nach Journals sortiert Quelle ... · Elevated HSP27 levels during attacks in patients with multiple sclerosis.....11 Multiple sclerosis and cognitive

Safety and Efficacy of Fingolimod in Schizophrenia ...€¦ · edema with or without visual symptoms occurred in 1.5% of patients (11/799) treated with fingolimod 1.25 mg, 0.5% of

Interleukin-22 is increased in multiple sclerosis patients and … · 2017-04-10 · RESEARCH Open Access Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes

Multiple Sclerosis · Multiple Sclerosis: MRI and Clinical Correlation 595 Fifty-three consecutive patients with suspected multiple sclerosis were studied to determine if the extent

Exome sequencing study in patients with multiple sclerosis

Curriculum Vitae et Studiorum Matteo Ruggeri€¦ · Italy and effects of fingolimod increased prescribing in second line treatment of relapsing-remitting multiple sclerosis. Global

Utilization of OCT in Patients with Multiple Sclerosis ... · So why are we concerned with Multiple Sclerosis as eye care practitioners? Well, Multiple Sclerosis and ocular changes

A Cohort Study of Cognitive Impairment in Patients Ofmultiple Sclerosis 2

Metabolomic profile of insulin resistance in patients with ... sclerosis and...Accepted Manuscript Metabolomic proÞle of insulin resistance in patients with multiple sclerosis is

THE CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS …€¦ · Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression:

Measuring the lesion load of multiple sclerosis patients ... › ~klein › publications › pdf › 2015... · Measuring the lesion load of multiple sclerosis patients within the

· 4 2. Background Fingolimod was approved for the treatment of relapsing forms of multiple sclerosis (MS) ... excluding changes in the bowel or bladder FS or cerebral FS. Study

Drug Class Review Disease-modifying Drugs for Multiple Sclerosis … · 2019. 1. 8. · In patients with relapsing-remitting multiple sclerosis, fingolimod 0.5 mg and 1.25 mg once

1982 Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients

Fingolimod en Esclerosis Múltiple